Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age5-17
SponsorUniversity of Oklahoma
About this trial
This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED), decrease length of stay (LOS) in the general hospital floor vs pediatric intensive care unit (PICU), and decrease the need for respiratory support.
Eligibility criteria
Qualifiers
Ages 5-17 years old
Presents to the ED with a respiratory score in the "Moderate" range (6
Parent(s)/Caregiver(s) speak English
Disqualifiers
Patients with chronic medical conditions including chronic pulmonary disease (other than asthma), cerebral palsy, congenital heart disease, tracheostomy dependent, myasthenia gravis patients
Patients who are pregnant
Parent(s)/Caregiver(s) do not speak English
Trial design
Treatments tested in this trial
- Magnesium Sulfate within the first hour
- No Magnesium sulfate within the first hour
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov